# Heimo Stroissnig

> Heimo Stroissnig is a startup investor at Baliopharm (Jülich). See 0 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Baliopharm](https://shizune.co/investors/profile/baliopharm)
- Location: Jülich, Germany
- Last updated: Aug 2026
- Website: http://www.baliopharm.com/

Heimo Stroissnig is a startup investor at Baliopharm in Jülich. Dr. Heimo Stroissnig joined Celonic AG in 2010 as Vice president clinical development and is now serving as the CMO for Baliopharm. He brings almost 30 years of experience in preclinical and clinical development gathered in both, mid-size pharma and small biotech. Within others he worked for CL-Pharma, Nycomed and Paion as well as a consultant formany biotech and pharma companies. Dr. Stroissnig obtained his M.D. after having studied medicine at the University of Graz and is board certified in pharmacology from the University of Vienna.

## About Baliopharm

VC Fund · Jülich, Germany

Baliopharm AG is a biotechnology company focusing on the development of novel therapeutics for the treatment of autoimmune diseases like rheumatoid arthritis, Crohn`s disease, psoriasis and multiple sclerosis, and for cancer.

2 contacts available at Baliopharm.

| Name | Title | Profile |
| --- | --- | --- |
| Andreas Herrmann | CEO and Founder | https://shizune.co/investors/profile/andreas-herrmann |
| Heimo Stroissnig | Chief Marketing Officer | https://shizune.co/investors/profile/heimo-stroissnig |

## FAQ

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co